Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanshan Pei

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Cell Stem Cell|January 22, 2013
BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cellsEleni D Lagadinou, Alexander Sach, Kevin Callahan, et al.
Cancer Cell|November 14, 2018
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem CellsCourtney L Jones, Brett M Stevens, Angelo D'Alessandro, et al.
Blood Advances|October 5, 2021
Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemiaEvan M Cherry, Diana Abbott, Maria Amaya, et al.
Clinical & Translational Immunology|July 4, 2025
Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1-RUNX1T1Yibo Wu, Xiaolin Yuan, Xiaoyu Lai, et al.
Nature Cancer|April 22, 2021
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cellsBrett M Stevens, Courtney L Jones, Daniel A Pollyea, et al.
Acta Pharmaceutica Sinica. B|January 1, 2026
Rational engineering of degradation tail-driven CELMoD-antibody conjugates for precision malignancy therapyYu Guo, Yi Song, Hanlin Wang, et al.
Journal of Hematology & Oncology|July 2, 2025
BRD4 acts as a transcriptional repressor of RhoB to inhibit terminal erythropoiesisYijin Chen, Dawei Huo, Ye Meng, et al.
Cell Metabolism|January 30, 2026
Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD<sup>+</sup> to eradicate KRAS-driven AMLAng Jia, Xiaowen Zhang, Ji-Hao Zhou, et al.
Bone Marrow Transplantation|March 30, 2025
Superior outcomes of haploidentical hematopoietic cell transplantation over chemotherapy in AML patients 55 years or olderLin Li, Lixia Zhu, Mengqi Xiong, et al.
Annals of Hematology|October 24, 2025
Developmental stage modulates the prognostic impact of RAS pathway mutations in AML patients undergoing Allo-HSCTXiaolin Yuan, Yibo Wu, Yanan Wang, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Cell Stem Cell|January 22, 2013
BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cellsEleni D Lagadinou, Alexander Sach, Kevin Callahan, et al.
Cancer Cell|November 14, 2018
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem CellsCourtney L Jones, Brett M Stevens, Angelo D'Alessandro, et al.
Blood Advances|October 5, 2021
Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemiaEvan M Cherry, Diana Abbott, Maria Amaya, et al.
Clinical & Translational Immunology|July 4, 2025
Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1-RUNX1T1Yibo Wu, Xiaolin Yuan, Xiaoyu Lai, et al.
Nature Cancer|April 22, 2021
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cellsBrett M Stevens, Courtney L Jones, Daniel A Pollyea, et al.
Acta Pharmaceutica Sinica. B|January 1, 2026
Rational engineering of degradation tail-driven CELMoD-antibody conjugates for precision malignancy therapyYu Guo, Yi Song, Hanlin Wang, et al.
Journal of Hematology & Oncology|July 2, 2025
BRD4 acts as a transcriptional repressor of RhoB to inhibit terminal erythropoiesisYijin Chen, Dawei Huo, Ye Meng, et al.
Cell Metabolism|January 30, 2026
Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD<sup>+</sup> to eradicate KRAS-driven AMLAng Jia, Xiaowen Zhang, Ji-Hao Zhou, et al.
Bone Marrow Transplantation|March 30, 2025
Superior outcomes of haploidentical hematopoietic cell transplantation over chemotherapy in AML patients 55 years or olderLin Li, Lixia Zhu, Mengqi Xiong, et al.
Annals of Hematology|October 24, 2025
Developmental stage modulates the prognostic impact of RAS pathway mutations in AML patients undergoing Allo-HSCTXiaolin Yuan, Yibo Wu, Yanan Wang, et al.
Pageof 6